Exactech Inc (EXAC)

30.95
NASDAQ : Health Care
Prev Close 30.95
Day Low/High 0.00 / 0.00
52 Wk Low/High 22.20 / 31.90
Avg Volume 30.20K
Exchange NASDAQ
Shares Outstanding 14.35M
Market Cap 441.92M
P/E Ratio 770.00
Div & Yield N.A. (N.A)

Latest News

Exactech Schedules Second Quarter 2017 Earnings Release And Conference Call

Exactech Schedules Second Quarter 2017 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its second quarter 2017 financial results on Thursday,...

Exactech Introduces New Computer-Assisted Software Application For Simplified Guidance In Total Knee Replacement

Exactech Introduces New Computer-Assisted Software Application For Simplified Guidance In Total Knee Replacement

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced the introduction of ExactechGPS® TKA PLUS, a new software...

Exactech Expands Presence In Japan With Newly Approved Shoulder, Knee And Hip Replacement Systems

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that the company marked the first clinical use of recently...

Alteon® HA Femoral Hip Stem Rounds Out Big Week Of First Surgeries For Exactech

Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced that the first surgeries using the new Alteon® HA Femoral Hip...

Exactech Announces Successful First Surgeries With New Equinoxe® Preserve Stem And ExactechGPS® Shoulder Application

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today a successful first surgery using the new Equinoxe®...

Exactech Announces Successful First Surgeries With Truliant® Knee System

Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, is pleased to announce that the first surgeries using the new Truliant®...

Exactech Receives 510(k) Clearance For Computer-Assisted Shoulder Arthroplasty Technology

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today it has received clearance from the U.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AKS, BPOP, CVV, EBF, EXAC, GWRE, KO, LNDC, RUSHA Downgrades: NLSN, VZ Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Exactech Q1 Revenue Up 6% To $69.5 Million On 21% Extremities Growth

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the first quarter of 2017 increased 6% to...

Exactech Schedules First Quarter 2017 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its first quarter 2017 financial results on Tuesday,...

Exactech New Scientific And Clinical Research Presented At 2017 Orthopaedic Research Society Annual Meeting

Exactech (Nasdaq:EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that 16 presentations featuring new scientific and clinical...

Exactech Announces Full Launch Of Three Revision Systems And Expansion Of Advanced Surgical Technologies At AAOS 2017 Annual Meeting, Exhibit #1433

Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today its lineup of products to be showcased at the company's...

Exactech Announces Investor Presentation At 12th Annual CanaccordGenuity Musculoskeletal Conference

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, will update investors at the 12th Annual CanaccordGenuity Musculoskeletal...

Bearish Bets: A Car Rental Giant, a Casino Operator and Other Stocks That Look Good Short

CAR, MGM, AAN, FSLR and EXAC all were recently downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABMD, ABX, AEM, BGG, BIIB, HBM, HTBI, KALU, MNTA, NEWM, NQ, SNE, VMI, VPG, WMT, XCRA Downgrades: CGNX, DAKT, EXAC, FSLR, HOLI, PFLT Initiations: AGR Read on to get TheStreet Quant Ratings' detailed report:

Exactech 2016 Revenue Up 7% To $257.6 Million, Q4'16 Revenue Increased 6% To $66.2 Million

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for 2016 increased 7% to $257.

Exactech Schedules Fourth Quarter And Year-End 2016 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its fourth quarter and year-end 2016 financial results...

Exactech Announces Divestiture Of Spine Assets And Restructuring Charges

With the goals of increasing productivity, enhancing profitability of its worldwide business, and strengthening its focus on core competencies, Exactech, Inc.

Exactech Q3 Revenue Up 7% To $59.9 Million. Net Income Up 10% To $3.2 Million. Diluted EPS $0.22 Vs. $0.20.

Exactech Q3 Revenue Up 7% To $59.9 Million. Net Income Up 10% To $3.2 Million. Diluted EPS $0.22 Vs. $0.20.

Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, extremity, spine and biologic materials, today announced revenue of $59.

Exactech Schedules Third Quarter 2016 Earnings Release And Conference Call

Exactech Schedules Third Quarter 2016 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, will release its third quarter financial results after the market closes on Monday,...

Exactech Breaks Ground In Foot And Ankle Market With Successful First Surgery

Exactech Breaks Ground In Foot And Ankle Market With Successful First Surgery

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, announced today a successful first surgery using its new Vantage® Total Ankle...

New Studies Support Exactech's Knee, Shoulder And Computer-Assisted Surgery Technologies

New Studies Support Exactech's Knee, Shoulder And Computer-Assisted Surgery Technologies

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today reported that studies involving its knee and shoulder joint replacement innovations and...

Exactech Expands Its Computer-Assisted Surgery System With Revision Total Knee Replacement Application

Exactech Expands Its Computer-Assisted Surgery System With Revision Total Knee Replacement Application

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today announced today the successful first U.

Dr. Pierre-Henri Flurin, MD, A Shoulder Specialist At The Clinique Du Sport In Bordeaux-Mérignac, France, Performed Both An Anatomic And A Reverse Total Shoulder Replacement Using Exactech's Equinoxe® Shoulder System Implants And Instruments. (Photo: Business Wire)

Dr. Pierre-Henri Flurin, MD, A Shoulder Specialist At The Clinique Du Sport In Bordeaux-Mérignac, France, Performed Both An Anatomic And A Reverse Total Shoulder Replacement Using Exactech's Equinoxe® Shoulder System Implants And Instruments. (Photo: Business Wire)

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today announced positive surgeon feedback on first surgeries performed with the...

Exactech Announces Investor Presentation At Baird Global Healthcare Conference

Exactech Announces Investor Presentation At Baird Global Healthcare Conference

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will present to investors at the Baird 2016 Global Healthcare Conference...

This Little-Known Orthopedic-Device Stock Is Delivering Huge Returns

This Little-Known Orthopedic-Device Stock Is Delivering Huge Returns

Even though it has huge, better-known rivals, Exactech (EXAC) is the best-performing stock in the orthopedic products sector this year.

Exactech Q2 Revenue Up 8% To $66.1 Million; Net Income Up 20% To $4.4 Million; Diluted EPS $0.31 Vs. $0.26

Exactech Q2 Revenue Up 8% To $66.1 Million; Net Income Up 20% To $4.4 Million; Diluted EPS $0.31 Vs. $0.26

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced revenue of $66.

Exactech Schedules Second Quarter 2016 Earnings Release And Conference Call

Exactech Schedules Second Quarter 2016 Earnings Release And Conference Call

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its second quarter financial results after the market...